Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schreiber Alain
Relationship:   10% Owner
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   12,051,047    

Indirect Shares

   11,491,339      
Direct Value   $30,089,302    

Indirect Value

   $2,719,247      
Total Shares   23,542,386      
Total Value   $32,808,549      


Molecular Templates, Inc. $81,877 Palatin Technologies Inc $12,246,381 Cadence Pharmaceuticals Inc $0 Optimer Pharmaceuticals Inc $0 Immune Design Corp. $0 Urogen Pharma Ltd. $17,761,043 Molecular Templates, Inc. $81,877 Palatin Technologies Inc $12,246,381 Cadence Pharmaceuticals Inc $0 Optimer Pharmaceuticals Inc $0 Immune Design Corp. $0 Urogen Pharma Ltd. $17,761,043
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Molecular Templates, Inc. MTEM 10% Owner 2005-10-28 136,417 2005-10-28 3,385,203    Premium*  
            Palatin Technologies Inc PTN 10% Owner 2005-11-29 5,803,972 2005-11-29 0    Premium*  
            Cadence Pharmaceuticals Inc CADX Director, 10% Owner 2007-09-19 2,882,269 2006-10-30 12,500    Premium*  
            Optimer Pharmaceuticals Inc OPTR Director 2008-07-18 2,500 2009-03-04 811,998    Premium*  
            Avanir Pharmaceuticals AVNR 10% Owner 2008-08-06 0 2009-10-13 7,125,754    Premium*  
            Eagle Pharmaceuticals, Inc. EGRX 10% Owner 0 2017-05-15 155,884    Premium*  
            Immune Design Corp. IMDZ 10% Owner 2015-05-12 1,983,858 2015-03-05 0    Premium*  
            Urogen Pharma Ltd. URGN 10% Owner 2017-11-28 1,242,031 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
URGN Urogen Pharma Ltd. 10% Owner   –       –       •   2017-11-28 4 S $40.51 $7,202,962 D/D (177,807) 1,242,031 0 -
URGN Urogen Pharma Ltd. 10% Owner   –       –       •   2017-11-27 4 S $41.12 $1,294,910 D/D (31,491) 1,419,838 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-05-15 4 A $0.00 $0 I/I 298,214 149,107 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-05-15 4 D $0.00 $0 I/I (3,584,087) 0 0 -
URGN Urogen Pharma Ltd. 10% Owner   –       –       •   2017-05-09 3 IO $0.00 $0 D/D 0 1,451,329 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-04-25 4 S $88.34 $4,788,482 I/I (54,180) 6,777 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-04-25 4 OE $0.90 $1,852,677 I/I 54,180 60,957 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-04-03 4 S $83.13 $5,105,845 I/I (61,420) 3,584,087 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-31 4 S $83.02 $1,966,661 I/I (23,689) 3,645,507 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-30 4 S $83.00 $516,509 I/I (6,223) 3,669,196 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-29 4 S $83.01 $5,051,574 I/I (60,855) 23,274 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-28 4 S $83.02 $513,230 I/I (6,182) 3,734,174 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-27 4 S $83.00 $3,272,773 I/I (39,431) 24,874 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-23 4 S $83.01 $58,107 I/I (700) 3,778,087 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-21 4 S $83.10 $41,550 I/I (500) 3,778,787 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-20 4 S $82.10 $4,259,594 I/I (51,883) 3,779,287 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-17 4 S $82.01 $3,198,144 I/I (38,997) 3,831,170 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-16 4 S $82.08 $748,570 I/I (9,120) 3,870,167 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-01-04 4 S $85.16 $5,545,108 I/I (65,114) 3,879,287 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2016-11-11 4 S $85.00 $1,321,835 I/I (15,551) 3,944,401 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2016-11-10 4 S $85.00 $1,614,770 I/I (18,935) 26,174 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2016-11-09 4 S $75.70 $11,818,065 I/I (148,800) 3,977,287 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2016-11-07 4 S $75.39 $379,212 I/I (5,030) 4,126,087 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2016-11-04 4 S $75.00 $3,462,750 I/I (46,170) 4,181,446 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2016-11-02 4 S $70.00 $13,992,635 I/I (199,600) 27,474 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us